Group | Day 4 | Day 5 | Day 6 | Day 7 |
---|
Normal | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
Negative control | 2.87 ± 0.59 | 1.26 ± 0.31 | 0.25 ± 0.16 | 0.00 ± 0.00 |
Loperamide | 1.51 ± 0.52 * | 0.11 ± 0.09 ** | 0.00 ± 0.00* | 0.00 ± 0.00 |
GOS 5% | 2.06 ± 0.24 a | 0.22 ± 0.24 ** | 0.00 ± 0.00* | 0.00 ± 0.00 |
GOS 10% | 1.64 ± 0.41 *a | 0.15 ± 0.04 ** | 0.00 ± 0.00* | 0.00 ± 0.00 |
GOS 15% | 1.18 ± 0.33 **b | 0.06 ± 0.04 ** | 0.00 ± 0.00* | 0.00 ± 0.00 |
- Normal, the uninfected-untreated control. Negative control, the infected-untreated control. Loperamide, the infected group with Loperamide-treatment (10 mg/kg). The 5, 10 and 15% GOS were the infected groups treated with corresponding concentration of GOS at a dose of 10 mL/kg, respectively. * P < 0.05 and ** P < 0.01, compared with the negative control. a, b Different letters indicate significant differences existed among the three GOS groups (P < 0.05). Data are presented as mean ± S.E.M. n = 16